Use of inhaled ciclesonide for treatment of moderate asthma in Thoroughbred racehorses
Use of inhaled ciclesonide for treatment of moderate asthma in Thoroughbred racehorses
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Mild-moderate asthma is common in horses. Inhaled ciclesonide has been approved only for treatment of severe asthma in horses.
We hypothesized that a 10-day treatment course of inhaled ciclesonide (Aservo EquiHaler) would improve clinical signs, endoscopic tracheal mucus scores, and bronchoalveolar lavage fluid (BALF) cytology in racehorses with...
Alternative Titles
Full title
Use of inhaled ciclesonide for treatment of moderate asthma in Thoroughbred racehorses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_cfc3ecaae9614f208c89e5c46abc558c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cfc3ecaae9614f208c89e5c46abc558c
Other Identifiers
ISSN
0891-6640,1939-1676
E-ISSN
1939-1676
DOI
10.1111/jvim.17267
